ATEC
Price
$11.38
Change
+$0.18 (+1.61%)
Updated
Apr 24, 02:17 PM (EDT)
Capitalization
1.9B
7 days until earnings call
GMED
Price
$73.35
Change
+$1.56 (+2.17%)
Updated
Apr 24, 02:30 PM (EDT)
Capitalization
7.19B
14 days until earnings call
Ad is loading...

ATEC vs GMED

Header iconATEC vs GMED Comparison
Open Charts ATEC vs GMEDBanner chart's image
Alphatec Holdings
Price$11.38
Change+$0.18 (+1.61%)
Volume$600
Capitalization1.9B
Globus Medical
Price$73.35
Change+$1.56 (+2.17%)
Volume$200
Capitalization7.19B
ATEC vs GMED Comparison Chart
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATEC vs. GMED commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Buy and GMED is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ATEC: $11.20 vs. GMED: $71.79)
Brand notoriety: ATEC and GMED are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATEC: 89% vs. GMED: 77%
Market capitalization -- ATEC: $1.9B vs. GMED: $7.19B
ATEC [@Medical Specialties] is valued at $1.9B. GMED’s [@Medical Specialties] market capitalization is $7.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • GMED’s FA Score: 1 green, 4 red.
According to our system of comparison, GMED is a better buy in the long-term than ATEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 4 TA indicator(s) are bullish while GMED’s TA Score has 6 bullish TA indicator(s).

  • ATEC’s TA Score: 4 bullish, 4 bearish.
  • GMED’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, GMED is a better buy in the short-term than ATEC.

Price Growth

ATEC (@Medical Specialties) experienced а +9.48% price change this week, while GMED (@Medical Specialties) price change was +0.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.08%. For the same industry, the average monthly price growth was -6.75%, and the average quarterly price growth was -2.65%.

Reported Earning Dates

ATEC is expected to report earnings on Jul 31, 2025.

GMED is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.19B) has a higher market cap than ATEC($1.9B). ATEC YTD gains are higher at: 22.004 vs. GMED (-13.203). GMED has higher annual earnings (EBITDA): 347M vs. ATEC (-110.59M). GMED has more cash in the bank: 518M vs. ATEC (221M). GMED (520M) and ATEC (542M) have identical debt. GMED has higher revenues than ATEC: GMED (1.57B) vs ATEC (482M).
ATECGMEDATEC / GMED
Capitalization1.9B7.19B26%
EBITDA-110.59M347M-32%
Gain YTD22.004-13.203-167%
P/E RatioN/A49.65-
Revenue482M1.57B31%
Total Cash221M518M43%
Total Debt542M520M104%
FUNDAMENTALS RATINGS
ATEC vs GMED: Fundamental Ratings
ATEC
GMED
OUTLOOK RATING
1..100
2074
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
5646
SMR RATING
1..100
9987
PRICE GROWTH RATING
1..100
3957
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMED's Valuation (85) in the Medical Specialties industry is in the same range as ATEC (98). This means that GMED’s stock grew similarly to ATEC’s over the last 12 months.

GMED's Profit vs Risk Rating (46) in the Medical Specialties industry is in the same range as ATEC (56). This means that GMED’s stock grew similarly to ATEC’s over the last 12 months.

GMED's SMR Rating (87) in the Medical Specialties industry is in the same range as ATEC (99). This means that GMED’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Price Growth Rating (39) in the Medical Specialties industry is in the same range as GMED (57). This means that ATEC’s stock grew similarly to GMED’s over the last 12 months.

GMED's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for ATEC (100). This means that GMED’s stock grew significantly faster than ATEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECGMED
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Ad is loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCIIX16.640.12
+0.73%
Brown Capital Mgmt Intl All Com Inv
NAPIX62.46N/A
N/A
Voya Multi-Manager International Sm Cp I
RNGCX52.09N/A
N/A
American Funds New Economy R3
RSESX14.75N/A
N/A
Russell Inv US Strategic Equity S
TOLLX16.71N/A
N/A
DWS RREEF Global Infrastructure A

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
+3.42%
LAB - ATEC
45%
Loosely correlated
-3.15%
GMED - ATEC
45%
Loosely correlated
+2.47%
TMCI - ATEC
42%
Loosely correlated
+2.40%
TFX - ATEC
36%
Loosely correlated
+1.20%
MYGN - ATEC
33%
Loosely correlated
-1.88%
More

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with ATEC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+2.47%
ATEC - GMED
45%
Loosely correlated
+3.42%
OFIX - GMED
44%
Loosely correlated
+2.13%
GKOS - GMED
43%
Loosely correlated
+3.21%
MXCT - GMED
43%
Loosely correlated
+2.93%
HBIO - GMED
40%
Loosely correlated
+0.97%
More